Anchored in work originally undertaken by, and licensed from Washington University (St. Louis), OsteoVantage is a biotechnology and medical device company is developing osteoinductive spinal instrumentation to enhance bone formation after spinal fusion surgery. The firm is structured around development of osteogenic spinal instrumentation technology judged likely to achieve better outcomes in spinal fusion surgery. The effort is to develop next-generation instrumentation and medical devices capable of minimizing pain, increasing mobility, and improving clinical outcomes via improved bone fusion technologies for those who have experienced back injuries, fractures, degenerative diseases, and other orthopedic, craniomaxillofacial and dental disorders. The defining vision is of the firm as a leader in what is being called Osteomodulation⢠â the technology of non-pharmacological remodeling of bone, through innovative research and seamless collaboration with orthopedic and neurosurgical thought leade
